CHRW vs EBS · P/E 37, rev $17.72B vs rev $1.04B
CH Robinson Worldwide Inc (CHRW) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
CH Robinson Worldwide Inc (CHRW) is a integrated freight & logistics company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CHRW revenue for 2024-12-31 was $17.72B. Net income was $465.7M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CHRW currently screens at market cap $21.70B and trailing P/E 37.3. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CHRW and EBS stock pages for the full models.
Not investment advice.